These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33220260)
1. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro. Jamalpour M; Bergquist E; Welsh M Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260 [TBL] [Abstract][Full Text] [Related]
2. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model. Fu JF; Yen TH; Huang YJ; Shih LY Neoplasia; 2019 May; 21(5):469-481. PubMed ID: 30974389 [TBL] [Abstract][Full Text] [Related]
3. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs. Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314 [TBL] [Abstract][Full Text] [Related]
4. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis. Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462 [TBL] [Abstract][Full Text] [Related]
5. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551 [TBL] [Abstract][Full Text] [Related]
6. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Wei J; Wunderlich M; Fox C; Alvarez S; Cigudosa JC; Wilhelm JS; Zheng Y; Cancelas JA; Gu Y; Jansen M; Dimartino JF; Mulloy JC Cancer Cell; 2008 Jun; 13(6):483-95. PubMed ID: 18538732 [TBL] [Abstract][Full Text] [Related]
7. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape. Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154 [TBL] [Abstract][Full Text] [Related]
8. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment? Muntean AG; Hess JL Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728 [TBL] [Abstract][Full Text] [Related]
9. An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Bergerson RJ; Collier LS; Sarver AL; Been RA; Lugthart S; Diers MD; Zuber J; Rappaport AR; Nixon MJ; Silverstein KA; Fan D; Lamblin AF; Wolff L; Kersey JH; Delwel R; Lowe SW; O'Sullivan MG; Kogan SC; Adams DJ; Largaespada DA Blood; 2012 May; 119(19):4512-23. PubMed ID: 22427200 [TBL] [Abstract][Full Text] [Related]
10. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia. Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652 [TBL] [Abstract][Full Text] [Related]
11. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. Thiel AT; Blessington P; Zou T; Feather D; Wu X; Yan J; Zhang H; Liu Z; Ernst P; Koretzky GA; Hua X Cancer Cell; 2010 Feb; 17(2):148-59. PubMed ID: 20159607 [TBL] [Abstract][Full Text] [Related]
12. Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia. Johnson JJ; Chen W; Hudson W; Yao Q; Taylor M; Rabbitts TH; Kersey JH Blood; 2003 Apr; 101(8):3229-35. PubMed ID: 12515728 [TBL] [Abstract][Full Text] [Related]
13. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model. Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576 [TBL] [Abstract][Full Text] [Related]
14. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Tan J; Jones M; Koseki H; Nakayama M; Muntean AG; Maillard I; Hess JL Cancer Cell; 2011 Nov; 20(5):563-75. PubMed ID: 22094252 [TBL] [Abstract][Full Text] [Related]
15. Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia. Zhang Y; Owens K; Hatem L; Glass CH; Karuppaiah K; Camargo F; Perkins AS Blood; 2013 Oct; 122(16):2888-92. PubMed ID: 24021671 [TBL] [Abstract][Full Text] [Related]
16. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. Nguyen AT; Taranova O; He J; Zhang Y Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783 [TBL] [Abstract][Full Text] [Related]
17. Disparate effects of Shb gene deficiency on disease characteristics in murine models of myeloid, B-cell, and T-cell leukemia. Jamalpour M; Li X; Gustafsson K; Tyner JW; Welsh M Tumour Biol; 2018 Apr; 40(4):1010428318771472. PubMed ID: 29792386 [TBL] [Abstract][Full Text] [Related]